Search Results - van Dongen, Guus AMS

EATRIS, a European initiative to boost translational biomedical research by van Dongen, Guus AMS, Ussi, Anton E, de Man, Frank H, Migliaccio, Giovanni

Get full text Get full text

Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets by Cohen, Ruth, Stammes, Marieke A, de Roos, Inge HC, Stigter-van Walsum, Marijke, Visser, Gerard WM, van Dongen, Guus AMS

Get full text Get full text Get full text

Preclinical evaluation of (89)Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys: Prelude to Phase 1 clinical studies by Vugts, Danielle J, Heuveling, Derrek A, Stigter-van Walsum, Marijke, Weigand, Stefan, Bergstrom, Mats, van Dongen, Guus AMS, Nayak, Tapan K

Get full text Get full text Get full text

Cerebral rituximab uptake in multiple sclerosis: A (89)Zr-immunoPET pilot study by Hagens, Marloes HJ, Killestein, Joep, Yaqub, Maqsood M, van Dongen, Guus AMS, Lammertsma, Adriaan A, Barkhof, Frederik, van Berckel, Bart NM

Get full text Get full text Get full text

The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by (89)Zr-immuno-PET in xenograft bearing mice by Chomet, Marion, Schreurs, Maxime, Nguyen, Margaret, Howng, Bruce, Villanueva, Ruth, Krimm, Michael, Vasiljeva, Olga, van Dongen, Guus A.M.S, Vugts, Danielle J.

Get full text Get full text Get full text

Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer by Bahce, Idris, Huisman, Marc C, Verwer, Eline E, Ooijevaar, Rogier, Boutkourt, Firdaouss, Vugts, Danielle J, van Dongen, Guus AMS, Boellaard, Ronald, Smit, Egbert F

Get full text Get full text Get full text

Development of [(11)C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts by Slobbe, Paul, Windhorst, Albert D., Adamzek, Kevin, Bolijn, Marije, Schuit, Robert C., Heideman, Daniëlle A.M., van Dongen, Guus A.M.S., Poot, Alex J.

Get full text Get full text Get full text

[(89)Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study by Adams, Human, van de Garde, Ewoudt MW, van Moorsel, Coline HM, Vugts, Danielle J, van Dongen, Guus AMS, Grutters, Jan C, Keijsers, Ruth G

Get full text Get full text

ImmunoPET Imaging of Renal Cell Carcinoma with (124)I- and (89)Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice by Stillebroer, Alexander B., Franssen, Gerben M., Mulders, Peter F.A., Oyen, Wim J.G., van Dongen, Guus A.M.S., Laverman, Peter, Oosterwijk, Egbert, Boerman, Otto C.

Get full text Get full text Get full text

A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies by Oliveira, Sabrina, Cohen, Ruth, Walsum, Marijke Stigter-van, van Dongen, Guus AMS, Elias, Sjoerd G, van Diest, Paul J, Mali, Willem, van Bergen en Henegouwen, Paul MP

Get full text Get full text Get full text

Performance of nanoScan PET/CT and PET/MR for quantitative imaging of (18)F and (89)Zr as compared with ex vivo biodistribution in tumor-bearing mice by Chomet, Marion, Schreurs, Maxime, Vos, Ricardo, Verlaan, Mariska, Kooijman, Esther J., Poot, Alex J., Boellaard, Ronald, Windhorst, Albert D., van Dongen, Guus AMS, Vugts, Danielle J., Huisman, Marc C., Beaino, Wissam

Get full text Get full text Get full text

A bi-paratopic anti-EGFR nanobody efficiently inhibits solid tumour growth by Roovers, Rob C., Vosjan, Maria J.W.D., Laeremans, Toon, el Khoulati, Rachid, de Bruin, Renée C.G., Ferguson, Kathryn M., Verkleij, Arie J., van Dongen, Guus A.M.S., van Bergen en Henegouwen, Paul M. P.

Get full text Get full text Get full text

F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational Approach by Bruijnen, Stefan T.G., Chandrupatla, Durga M.S.H., Giovanonni, Leonardo, Neri, Dario, Vugts, Danielle J., Huisman, Marc C., Hoekstra, Otto S., Musters, René J.P., Lammertsma, Adriaan A., van Dongen, Guus A.M.S., Jansen, Gerrit, Molthoff, Carla F.M., van der Laken, Conny J.

Get full text Get full text Get full text

Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach by Even, Aniek J.G., Hamming-Vrieze, Olga, van Elmpt, Wouter, Winnepenninckx, Véronique J.L., Heukelom, Jolien, Tesselaar, Margot E.T., Vogel, Wouter V., Hoeben, Ann, Zegers, Catharina M.L., Vugts, Daniëlle J., van Dongen, Guus A.M.S., Bartelink, Harry, Mottaghy, Felix M., Hoebers, Frank, Lambin, Philippe

Get full text Get full text Get full text

(89)Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding by van Brummelen, Emilie M.J., Huisman, Marc C., de Wit-van der Veen, Linda J., Nayak, Tapan K., Stokkel, Marcel P.M., Mulder, Emma R., Hoekstra, Otto S., Vugts, Danielle J., Van Dongen, Guus A.M.S., Verheul, Henk M., Evers, Stefan, Tessier, Jean J. L., Saro, Jose, Schellens, Jan H.M., Menke-van der Houven van Oordt, C. Willemien

Get full text Get full text Get full text

The NHance(®) Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients by Aftimos, Philippe, Rolfo, Christian, Rottey, Sylvie, Barthélémy, Philippe, Borg, Christophe, Park, Keunchil, Oh, Do-Youn, Kim, Sang-We, De Jonge, Natalie, Hanssens, Valérie, Zwanenpoel, Karen, Molthoff, Carla, Vugts, Daniëlle, Dreier, Torsten, Verheesen, Peter, van Dongen, Guus A.M.S., Jacobs, Julie, Van Rompaey, Luc, Hultberg, Anna, Michieli, Paolo, Pauwels, Patrick, Fung, Samson, Thibault, Alain, de Haard, Hans, Leupin, Nicolas, Awada, Ahmad

Get full text Get full text Get full text